Post COVID pulmonary complications – A case series
COVID-19 patients are frequently coinfected by other microbial pathogens, adding to the severity of the cases and raising difficulty in the diagnosis, prognosis, and treatment. Pulmonary mucormycosis and invasive Aspergillosis are such life-threatening fungal infections. Risk factors include uncontr...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | Journal of Association of Pulmonologist of Tamil Nadu |
| Subjects: | |
| Online Access: | http://www.japt.in/article.asp?issn=2772-6355;year=2021;volume=4;issue=2;spage=78;epage=81;aulast=Palaninathan |
| _version_ | 1797738613686927360 |
|---|---|
| author | Prem Ananth Palaninathan Divya Mary Elias Nagarajan Nagasubramanian Prathipa Ramakrishnan |
| author_facet | Prem Ananth Palaninathan Divya Mary Elias Nagarajan Nagasubramanian Prathipa Ramakrishnan |
| author_sort | Prem Ananth Palaninathan |
| collection | DOAJ |
| description | COVID-19 patients are frequently coinfected by other microbial pathogens, adding to the severity of the cases and raising difficulty in the diagnosis, prognosis, and treatment. Pulmonary mucormycosis and invasive Aspergillosis are such life-threatening fungal infections. Risk factors include uncontrolled diabetes mellitus, hematological malignancies, solid organ transplantation, and chronic renal failure. Pulmonary emboli and pneumothorax have also been reported frequently in COVID-19 patients, especially in those who required invasive mechanical ventilation. Herein, we report four different cases of post COVID pulmonary complications. All four patients were evaluated with computed tomography thorax. Two patients had necrotizing pneumonia and sputum culture grew mucor and Aspergillus species, respectively. They were treated with intravenous antifungals. One patient had rifampicin-sensitive pulmonary tuberculosis (TB) and was started on antitubercular drugs. Both pulmonary mucormycosis and pulmonary TB patients had a segmental and subsegmental pulmonary embolism. They were managed with low-molecular-weight heparin. One patient had left pneumothorax, for which intercostal drainage was placed. |
| first_indexed | 2024-03-12T13:46:21Z |
| format | Article |
| id | doaj.art-b3deb24a7a8a4c5283dd8b833f855531 |
| institution | Directory Open Access Journal |
| issn | 2772-6355 2772-6363 |
| language | English |
| last_indexed | 2024-03-12T13:46:21Z |
| publishDate | 2021-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Association of Pulmonologist of Tamil Nadu |
| spelling | doaj.art-b3deb24a7a8a4c5283dd8b833f8555312023-08-23T09:08:17ZengWolters Kluwer Medknow PublicationsJournal of Association of Pulmonologist of Tamil Nadu2772-63552772-63632021-01-0142788110.4103/japt.japt_34_21Post COVID pulmonary complications – A case seriesPrem Ananth PalaninathanDivya Mary EliasNagarajan NagasubramanianPrathipa RamakrishnanCOVID-19 patients are frequently coinfected by other microbial pathogens, adding to the severity of the cases and raising difficulty in the diagnosis, prognosis, and treatment. Pulmonary mucormycosis and invasive Aspergillosis are such life-threatening fungal infections. Risk factors include uncontrolled diabetes mellitus, hematological malignancies, solid organ transplantation, and chronic renal failure. Pulmonary emboli and pneumothorax have also been reported frequently in COVID-19 patients, especially in those who required invasive mechanical ventilation. Herein, we report four different cases of post COVID pulmonary complications. All four patients were evaluated with computed tomography thorax. Two patients had necrotizing pneumonia and sputum culture grew mucor and Aspergillus species, respectively. They were treated with intravenous antifungals. One patient had rifampicin-sensitive pulmonary tuberculosis (TB) and was started on antitubercular drugs. Both pulmonary mucormycosis and pulmonary TB patients had a segmental and subsegmental pulmonary embolism. They were managed with low-molecular-weight heparin. One patient had left pneumothorax, for which intercostal drainage was placed.http://www.japt.in/article.asp?issn=2772-6355;year=2021;volume=4;issue=2;spage=78;epage=81;aulast=Palaninathaninvasive aspergillosispulmonary embolismpulmonary mucormycosispulmonary tuberculosis |
| spellingShingle | Prem Ananth Palaninathan Divya Mary Elias Nagarajan Nagasubramanian Prathipa Ramakrishnan Post COVID pulmonary complications – A case series Journal of Association of Pulmonologist of Tamil Nadu invasive aspergillosis pulmonary embolism pulmonary mucormycosis pulmonary tuberculosis |
| title | Post COVID pulmonary complications – A case series |
| title_full | Post COVID pulmonary complications – A case series |
| title_fullStr | Post COVID pulmonary complications – A case series |
| title_full_unstemmed | Post COVID pulmonary complications – A case series |
| title_short | Post COVID pulmonary complications – A case series |
| title_sort | post covid pulmonary complications a case series |
| topic | invasive aspergillosis pulmonary embolism pulmonary mucormycosis pulmonary tuberculosis |
| url | http://www.japt.in/article.asp?issn=2772-6355;year=2021;volume=4;issue=2;spage=78;epage=81;aulast=Palaninathan |
| work_keys_str_mv | AT premananthpalaninathan postcovidpulmonarycomplicationsacaseseries AT divyamaryelias postcovidpulmonarycomplicationsacaseseries AT nagarajannagasubramanian postcovidpulmonarycomplicationsacaseseries AT prathiparamakrishnan postcovidpulmonarycomplicationsacaseseries |